TuHURA
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Our Founders
  • Technologies
    • IMMUNE FX (IFX): Innate Immune Agonist
    • TBS-2025
    • Bi-Specific Immune Modulating Antibody Drug Conjugates (ADCs)
    • Scientific Publications
  • Pipeline
    • Overview
    • IFX-2.0
    • TBS-2025
    • DOR Technology
  • Clinical Studies
    • IFX-2.0: Phase 3 Registration Trial
  • Investors
    • Overview
    • Press Releases
    • Events
    • Company Information
      • Overview
      • Management Team
    • Stock Information
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
      • Overview
      • Board of Directors
    • IR Contacts
    • Email Alerts
  • News
    • Press Releases
    • Email Alerts
  • Contact Us
Select Page
10500 University Center Drive
Suite 110
Tampa FL 33612
813-875-6600
info@tuhurabio.com
About
News
Contact 

 

 

IR Contact
Monique Kosse
Gilmartin Group
813-875-6600
info@tuhurabio.com

Copyright 2025, TuHURA Biosciences, Inc.   All Rights Reserved

         Privacy Policy     Terms of Use

  • Follow
  • Follow
  • Follow